Cargando…
Harnessing the Immune System to Fight Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma treatment has developed enormously within the last two decades. Most recently immunotherapies have been introduced. Monoclonal antibodies targeting the plasma cell surface marker CD38, daratumumab and isatuximab, have revolutionized the standard of care treatment, an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467095/ https://www.ncbi.nlm.nih.gov/pubmed/34572773 http://dx.doi.org/10.3390/cancers13184546 |